Identifying tumor cell growth inhibitors by combinatorial chemistry and zebrafish assays

scientific article published in 2009

Identifying tumor cell growth inhibitors by combinatorial chemistry and zebrafish assays is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2009PLoSO...4.4361X
P356DOI10.1371/JOURNAL.PONE.0004361
P3181OpenCitations bibliographic resource ID4506420
P932PMC publication ID2633036
P698PubMed publication ID19194508
P5875ResearchGate publication ID23980945

P50authorZhen YangQ38304491
P2093author name stringHui Zhang
Junmin Quan
Shuo Lin
Jing Xiang
Yuquan Wei
Hongbo Yang
Chao Che
Haixia Zou
Hanshuo Yang
P2860cites work3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 1. Lead findingQ24296298
N2-substituted O6-cyclohexylmethylguanine derivatives: potent inhibitors of cyclin-dependent kinases 1 and 2Q24298676
Cyclin A is required at two points in the human cell cycleQ24329048
Coordinate control of cell cycle regulatory genes in zebrafish development tested by cyclin D1 knockdown with morpholino phosphorodiamidates and hydroxyprolyl-phosphono peptide nucleic acidsQ24811143
Stages of embryonic development of the zebrafishQ27860947
Chromosome 11q13 abnormalities in human breast cancerQ28243938
The regulation of E2F by pRB-family proteinsQ28278789
Cell cycle kinases in cancerQ28282263
Cancer cell cyclesQ29547756
Cyclin-dependent kinases: engines, clocks, and microprocessorsQ29614786
Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma developmentQ51193082
Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activationQ52166351
Multiple-Component Condensation Strategies for Combinatorial Library SynthesisQ56068727
Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy functionQ56885198
Expression of cell cycle regulatory proteins in chronic lymphocytic leukemias. Comparison with non-Hodgkin's lymphomas and non-neoplastic lymphoid tissueQ71979672
Inhibitors of cyclin-dependent kinases as anti-cancer therapeuticsQ73081293
One-pot synthesis of quinoline-based tetracycles by a tandem three-component reactionQ80810091
Erratum [McMahon G, Sun L, Liang C, Tang C: Protein kinase inhibitors: structural determinants for target specificity. Current Opin Drug Discovery Dev (1998) 1(2):131-146. Correction to the structure of Compound 74 (SU-5874) in Figure 9]Q84337647
A New Heterocyclic Multicomponent Reaction For the Combinatorial Synthesis of Fused 3-AminoimidazolesQ88520514
A New Staurosporine Analog from the Prosobranch MolluskCoriocella NigraQ105035250
Crystal structure of cyclin-dependent kinase 2Q29622946
Multicomponent Reactions with Isocyanides.Q30940111
Maximizing synthetic efficiency: multi-component transformations lead the wayQ30946007
Small molecules that delay S phase suppress a zebrafish bmyb mutantQ33230169
Protein-tyrosine kinase activity profiling in knock down zebrafish embryosQ33289953
Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinomaQ33493133
Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitorsQ33604662
How the cyclin became a cyclin: regulated proteolysis in the cell cycleQ33641413
The development and therapeutic potential of protein kinase inhibitorsQ33695725
Properties and potential-applications of chemical inhibitors of cyclin-dependent kinasesQ33716146
Anticancer drug targets: cell cycle and checkpoint control.Q33801116
Cyclin-dependent kinase inhibitors: useful targets in cell cycle regulationQ33815989
To cycle or not to cycle: a critical decision in cancer.Q33957955
The retinoblastoma gene: a prototypic and multifunctional tumor suppressorQ34174294
Small molecules as inhibitors of cyclin-dependent kinasesQ35133499
Recent advances in the development of selective small molecule inhibitors for cyclin-dependent kinasesQ36107332
Small molecule developmental screens reveal the logic and timing of vertebrate developmentQ37276174
Inhibition of cytokine production by hymenialdisine derivatives.Q40542126
A new series of potent oxindole inhibitors of CDK2.Q40580263
Immunohistochemical expression of cyclin E in endometrial adenocarcinoma (endometrioid type) and its clinicopathological significanceQ44396620
Anilinopyrazole as selective CDK2 inhibitors: design, synthesis, biological evaluation, and X-ray crystallographic analysisQ44563585
Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinasesQ44754701
Imidazo[1,2-b]pyridazines: a potent and selective class of cyclin-dependent kinase inhibitorsQ44841683
Tandem reactions, cascade sequences, and biomimetic strategies in total synthesisQ46131918
Synthesis of Complex Carbohydrates and Glycoconjugates: Enzyme-Based and Programmable One-Pot StrategiesQ46722058
Recent progress towards the identification of selective inhibitors of serine/threonine protein kinasesQ47832770
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectDanio rerioQ169444
cell growthQ189159
P304page(s)e4361
P577publication date2009-01-01
P1433published inPLOS OneQ564954
P1476titleIdentifying tumor cell growth inhibitors by combinatorial chemistry and zebrafish assays
P478volume4